Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Jill Roberts Center for Inflammatory Bowel Disease
Explore this Website
Home
About Us
Toggle About Us menu options
Clinical Staff
Research Staff
Contact Us
Newsworthy
Toggle Newsworthy menu options
News and Announcements
Patient Care
Toggle Patient Care menu options
Clinical Services
FAQs
For Your Visit
COVID-19 Information
Nutrition Science
Toggle Nutrition Science menu options
Nutrition FAQs
Food Intolerances
News in IBD Nutrition
Research and Clinical Trials
Toggle Research and Clinical Trials menu options
Clinical Trials
Publications
Weill Cornell Medicine
Care
Discover
Teach
Home
About Us
Newsworthy
Patient Care
Nutrition Science
Research and Clinical Trials
Home
Publications
Publications
Clinical Trials
Publications
Found 48 results
Author
[
Title
]
Type
Year
Filters:
First Letter Of Last Name
is
G
[Clear All Filters]
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
V
Gordon BL
,
Galati J
,
Yang S
,
Katz PO
,
Scherl EJ
. 2020.
Vitamin C Deficiency: An Under-Recognized Condition in Crohn's Disease.
.
ACG Case Rep J. 7(7):e00424.
Gordon BL
,
Galati J
,
Yang S
,
Katz PO
,
Scherl EJ
. 2020.
Vitamin C Deficiency: An Under-Recognized Condition in Crohn's Disease.
.
ACG Case Rep J. 7(7):e00424.
Narula N
,
Peerani F
,
Meserve J
,
Kochhar G
,
Chaudrey K
,
Hartke J
,
Chilukuri P
,
Koliani-Pace J
,
Winters A
,
Katta L
et al.
. 2018.
Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium.
.
Am J Gastroenterol. 113(9):1345.
U
Gold SL
,
Magro C
,
Scherl E
. 2018.
A Unique Infusion Reaction to Vedolizumab in a Patient With Crohn's Disease.
.
Gastroenterology. 155(4):981-982.
T
Lima S
,
Gogokhia L
,
Viladomiu M
,
Chou L
,
Putzel G
,
Jin W
,
Pires S
,
Guo C-J
,
Gerardin Y
,
Crawford CV
et al.
. 2021.
Transferable Immunoglobulin A-Coated Odoribacter splanchnicus in Responders to Fecal Microbiota Transplantation for Ulcerative Colitis Limits Colonic Inflammation.
.
Gastroenterology.
Lima S
,
Gogokhia L
,
Viladomiu M
,
Chou L
,
Putzel G
,
Jin W
,
Pires S
,
Guo C-J
,
Gerardin Y
,
Crawford CV
et al.
. 2021.
Transferable Immunoglobulin A-Coated Odoribacter splanchnicus in Responders to Fecal Microbiota Transplantation for Ulcerative Colitis Limits Colonic Inflammation.
.
Gastroenterology.
Lima S
,
Gogokhia L
,
Viladomiu M
,
Chou L
,
Putzel G
,
Jin W
,
Pires S
,
Guo C-J
,
Gerardin Y
,
Crawford CV
et al.
. 2021.
Transferable Immunoglobulin A-Coated Odoribacter splanchnicus in Responders to Fecal Microbiota Transplantation for Ulcerative Colitis Limits Colonic Inflammation.
.
Gastroenterology.
S
Koczka CPhilip
,
Abramowitz M
,
Goodman AJ
. 2012.
The study of bone demineralization and its risk factors in an Afro-Caribbean subset of patients with inflammatory bowel disease.
.
Eur J Gastroenterol Hepatol. 24(7):759-61.
Jacob V
,
Crawford C
,
Cohen-Mekelburg S
,
Viladomiu M
,
Putzel GG
,
Schneider Y
,
Chabouni F
,
OʼNeil S
,
Bosworth B
,
Woo V
et al.
. 2017.
Single Delivery of High-Diversity Fecal Microbiota Preparation by Colonoscopy Is Safe and Effective in Increasing Microbial Diversity in Active Ulcerative Colitis.
.
Inflamm Bowel Dis. 23(6):903-911.
Faleck DM
,
Winters A
,
Chablaney S
,
Shashi P
,
Meserve J
,
Weiss A
,
Aniwan S
,
Koliani-Pace JL
,
Kochhar G
,
Boland BS
et al.
. 2019.
Shorter Disease Duration Is Associated With Higher Rates of Response to Vedolizumab in Patients With Crohn's Disease But Not Ulcerative Colitis.
.
Clin Gastroenterol Hepatol. 17(12):2497-2505.e1.
Zhang S
,
Dogan B
,
Guo C
,
Herlekar D
,
Stewart K
,
Scherl EJ
,
Simpson KW
. 2020.
Short Chain Fatty Acids Modulate the Growth and Virulence of Pathosymbiont and Host Response.
.
Antibiotics (Basel). 9(8)
Gu W
,
Wang H
,
Huang X
,
Kraiczy J
,
Singh PNP
,
Ng C
,
Dagdeviren S
,
Houghton S
,
Pellon-Cardenas O
,
Lan Y
et al.
. 2021.
SATB2 preserves colon stem cell identity and mediates ileum-colon conversion via enhancer remodeling.
.
Cell Stem Cell.
R
Cohen-Mekelburg S
,
Schneider Y
,
Gold S
,
Ghosh G
,
Rosenblatt R
,
Hajifathalian K
,
Scherl E
,
Schnoll-Sussman F
,
Katz P
,
Steinlauf A
. 2019.
Risk of Early Colorectal Cancers Needs to Be Considered in Inflammatory Bowel Disease Care.
.
Dig Dis Sci. 64(8):2273-2279.
Cohen-Mekelburg S
,
Schneider Y
,
Gold S
,
Ghosh G
,
Rosenblatt R
,
Hajifathalian K
,
Scherl E
,
Schnoll-Sussman F
,
Katz P
,
Steinlauf A
. 2019.
Risk of Early Colorectal Cancers Needs to Be Considered in Inflammatory Bowel Disease Care.
.
Dig Dis Sci. 64(8):2273-2279.
Longman RS
,
Moreira RK
,
Littman DR
,
Green PHR
,
Sethi A
. 2012.
A rare intestinal infection with systemic effects.
.
Gastroenterol Hepatol (N Y). 8(1):60-3.
P
Shmidt E
,
Kochhar G
,
Hartke J
,
Chilukuri P
,
Meserve J
,
Chaudrey K
,
Koliani-Pace JL
,
Hirten R
,
Faleck D
,
Barocas M
et al.
. 2018.
Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease.
.
Inflamm Bowel Dis. 24(11):2461-2467.
Ghosh G
,
Jacob V
,
Wan D
. 2018.
Plasmablastic Lymphoma in a Patient With Crohn's Disease After Extensive Immunosuppressive Therapy.
.
Clin Gastroenterol Hepatol. 16(4):e41-e42.
Shen T-CDavid
,
Lebwohl B
,
Verma H
,
Kumta N
,
Tennyson C
,
Lewis S
,
Scherl E
,
Swaminath A
,
Capiak KM
,
DiGiacomo D
et al.
. 2012.
Peripheral neuropathic symptoms in celiac disease and inflammatory bowel disease.
.
J Clin Neuromuscul Dis. 13(3):137-45.
M
Dogan B
,
Scherl E
,
Bosworth B
,
Yantiss R
,
Altier C
,
McDonough PL
,
Jiang Z-D
,
Dupont HL
,
Garneau P
,
Harel J
et al.
. 2013.
Multidrug resistance is common in Escherichia coli associated with ileal Crohn's disease.
.
Inflamm Bowel Dis. 19(1):141-50.
Castellanos JG
,
Woo V
,
Viladomiu M
,
Putzel G
,
Lima S
,
Diehl GE
,
Marderstein AR
,
Gandara J
,
Perez AR
,
Withers DR
et al.
. 2018.
Microbiota-Induced TNF-like Ligand 1A Drives Group 3 Innate Lymphoid Cell-Mediated Barrier Protection and Intestinal T Cell Activation during Colitis.
.
Immunity. 49(6):1077-1089.e5.
Diehl GE
,
Longman RS
,
Zhang J-X
,
Breart B
,
Galan C
,
Cuesta A
,
Schwab SR
,
Littman DR
. 2013.
Microbiota restricts trafficking of bacteria to mesenteric lymph nodes by CX(3)CR1(hi) cells.
.
Nature. 494(7435):116-20.
Harris A
,
Eswaran S
,
Bosworth B
,
Gambarin-Gelwan M
,
Scherl EJ
. 2007.
Mesalamine-induced Pneumonitis and Serum Sickness-like Reaction.
.
Gastroenterol Hepatol (N Y). 3(11):875-7.
L
Steinlauf AF
,
Garcia-Tsao G
,
Zakko MF
,
Dickey K
,
Gupta T
,
Groszmann RJ
. 1999.
Low-dose midazolam sedation: an option for patients undergoing serial hepatic venous pressure measurements.
.
Hepatology. 29(4):1070-3.
Steinlauf AF
,
Garcia-Tsao G
,
Zakko MF
,
Dickey K
,
Gupta T
,
Groszmann RJ
. 1999.
Low-dose midazolam sedation: an option for patients undergoing serial hepatic venous pressure measurements.
.
Hepatology. 29(4):1070-3.
Steinlauf AF
,
Garcia-Tsao G
,
Zakko MF
,
Dickey K
,
Gupta T
,
Groszmann RJ
. 1999.
Low-dose midazolam sedation: an option for patients undergoing serial hepatic venous pressure measurements.
.
Hepatology. 29(4):1070-3.
1
(current)
2
next ›
last »